Biotech. Stocks Alert: Exelixis, Inovio Pharmaceuticals, Oncolytics Biotech, Vertex Pharmaceuticals Incorporated

Lakeway, TX -- (SBWIRE) -- 02/21/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Exelixis, Inc. (NASDAQ:EXEL) shares fell 1.67% and closed at $4.72. Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184). It also has a portfolio of other compounds. Cabozantinib is the inhibitor of MET in clinical development and is being evaluated in a development program encompassing multiple cancer indications.

How Should Investors Trade EXEL After The Recent Movement? Find Out Here

Inovio Pharmaceuticals, Inc. (NYSE:INO) shares lost 1.35% to $0.732. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).

Is INO Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) shares decreased 16.49% and closed at $3.90. Oncolytics Biotech Inc. (Oncolytics) is a development-stage company. The Company is focused on its research and development of REOLYSIN, which is its cancer therapeutic. REOLYSIN is developed from the reovirus. This virus has been demonstrated in tumour cells bearing an activated Ras pathway.

Is ONCY a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares decreased 2.32% and closed at $45.44. Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases.

How Should Investors Trade VRTX After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.